Clinical Trial Update: Concentration and Activity of Lapatinib in Vestibular Schwannomas [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial updating concentration and activity of lapatinib in vestibular schwannomas, completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type 2
• Vestibular Schwannoma

Drugs mentioned

• Lapatinib (Lapatinib)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Vestibular Schwannoma, NF2 | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2018-11-26